The Effect of the Elapsed Time Between Blood Draw and Processing on the Recovery of Fetal Cells From Maternal Blood

Abstract

Objective: To test the hypothesis that a delay in initial fetal cell enrichment processing of maternal blood samples (defined as the time between blood draw and the initial density gradient centrifugation step) compromises the ability to recover fetal cells, we performed a randomized comparison of immediate (within 4 hours of draw) versus delayed (between 18-24 hours of draw) processing.

Methods: Four centers participated: two centers utilized flow cytometry (FLOW), and two centers utilized magnetic-activated cell sorting (MACS) techniques. Each center collected 34 samples. The outcome was the percentage of gamma positive (γ⁺) cells for FLOW or the number of nucleated red blood cells (NRBCs) for MACS, found in the final enriched cell population. Both outcomes reflect cell properties that are potentially fetal in origin, thus making them representative of the ability to recover fetal cells.

Results: Our results did not support our hypothesis that delay in processing compromises fetal cell recovery. Instead, in MACS processing, we observed an increase in recovered NRBCs when blood sample processing was delayed compared with immediate processing. There was no significant difference in γ⁺ cells with FLOW.

Conclusion: Time-related changes in the density of target cells, perhaps associated with their progress towards apoptosis during the delay period, may result in increased intact fetal cells with the study methods utilized.

Keywords

Fetal cells in maternal blood noninvasive prenatal diagnosis fetal cell recovery

Get full access to this article

View all access options for this article.

References

1. De la Cruz F , Shifrin H , Elias S , et al. Prenatal diagnosis by use of fetal cells isolated by use of fetal cells isolated from maternal blood. Am J Obstet Gynecol 1995;173:1354-1355.

2. Bianchi DW , Simpson JL , Jackson LG , et al. Fetal cells in maternal blood: NIFTY clinical trial interim analysis. Prenat Diagn 1999;19:994-995.

3. Bischoff FZ , Lewis DE , Nguyen DD , et al. Prenatal diagnosis with use of fetal cells isolated from maternal blood: Five-color fluorescent in situ hybridization analysis on flow-sorted cells for chromosomes X,Y,13,18, and 21. Am J Obstet Gynecol 1998;179:203-209.

4. Bianchi DW , Simpson JL Jackson LG , et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: Analysis of NIFTY I data. Prenat Diagn 2002;22:609-615.

5. Zheng YL , Zhen DK , DeMaria MA , et al. Search for the optimal fetal cell antibody: R esults of immunophenotyping studies using flow cytometry. Hum Genet 1997;100:35-42.

6. DeMaria MA , Zheng YL , Zhen D , Weinschenk NM , Vadnais TJ , Bianchi DW . Improved fetal nucleated erythrocyte-sorting purity using intracellular antifetal hemoglobin and Hoechst 33342. Cytometry 1996;25:37-45.

7. Lewis DE , Schober W , Murrell S , et al. Rare event selection of fetal nucleated erythrocytes in maternal blood by flow cytometry. Cytometry 1996;23:218-227.

8. Wang JY , Zhen DK , Falco VM , et al. Fetal nucleated erythrocyte recovery: Fluorescence-activated cell sorting based positive selection using anti-gamma globin versus magnetic-activated cell sorting using anti-CD45 depletion and anti-gamma positive selection. Cytometry 2003;39:224-230.

9. Ganshirt D , Smeets FW , Dohr A , et al. Enrichment of fetal nucleated red blood cells from the maternal circulation for prenatal diagnosis: Experiences with triple density graidnet and MACS based on more than 600 cases. Fetal Diagn Ther 1998;13:276-286.

10.

10. Troeger C , Holzgreve W , Hahn S . A comparison of different density gradients and antibodies for enrichment of fetal erythroblasts by MACS. Prenat Diagn 1999;19:521-526.

11.

11. Samura O , Sekizawa A , Zhen DK , Falco VM , Bianchi DW . Comparison of fetal cell recovery from maternal blood using a high density gradient for the initial separation step: 1.090 versus 1.119 g/ml. Prenat Diagn 2000;20:281-286.

12.

12. Van Wijk IJ , de Hoon AC , Jurhawan R , et al. Detection of apoptotic fetal cells in plasma of pregnant women. Clin Chem 2000;46:1832-1834.

13.

13. Poon LL , Leung TN , Lau TK , Lo YM . Prenatal detection of fetal Down's syndrome from maternal plasma. Lancet 2000;356:1819-1820.

14.

14. Sekizawa A , Samura O , Zhen DK , Falco V , Farina A , Bianchi DW . Apoptosis in fetal nucleated erythrocytes circulating in maternal blood. Prenat Diagn 2000;20:886-889.

15.

15. Kolialexi A , Tsangaris GT , Antsaklis A , et al. Apoptosis in maternal peripheral blood during pregnancy. Fetal Diagn Ther 2001;16:32-37.

16.

16. Hristoskova S , Holzgreve W , Hahn S . More than one-half of the erythroblasts in the fetal circulation and cord blood are TUNEL positive. Clin Chem 2001;47:1870-1871.

17.

17. Sekizawa A , Farina A , Zhen DK , et al. Improvement of fetal cell recovery from maternal blood: Suitable density gradient for FACS separation. Fetal Diagn Ther 1999;14:229-233.

18.

18. Smits G , Holzgreve W , Hahn S . An examination of different Percoll density gradients and magnetic-activated cell sorting (MACS) for the enrichment of fetal erythroblasts from maternal blood. Arch Gynecol Obstet 2000;263:160-163.